Lineage Cell Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Lineage Cell Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2024.
  • Lineage Cell Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $14M.
  • Lineage Cell Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $6.42M, a 294% increase from 2022.
  • Lineage Cell Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.63M, a 95.6% decline from 2021.
  • Lineage Cell Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $36.9M, a 23.7% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $14M +$14M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $1K* -$512K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $513K -$20.5M -97.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $21M +$31M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 -$10M -$10.6M -1750% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $606K -$27K -4.27% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $633K -$18.5M -96.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $19.1M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2014 $12.1M -$985K -7.51% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-12
Q1 2013 $13.1M +$13.1M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q1 2012 $0 -$690K -100% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 $690K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.